These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 10160053)
1. The U.S. Pharmacopeia's role in establishing public standards for aerosols. Srinivasan V J Aerosol Med; 1996 Mar; 9 Suppl 1():S13-7. PubMed ID: 10160053 [TBL] [Abstract][Full Text] [Related]
2. Laser diffractometry and cascade impaction for nebulizer product characterization. Mitchell JP; Tservistas M Pharmeur Sci Notes; 2006 Dec; 2006(2):49-52. PubMed ID: 17691215 [TBL] [Abstract][Full Text] [Related]
3. Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations. Mitchell JP; Nagel MW J Aerosol Med; 2003; 16(4):341-77. PubMed ID: 14977427 [TBL] [Abstract][Full Text] [Related]
4. Metered-dose inhalers, I: Drug content and particle size distribution of beclomethasone dipropionate. LeBelle M; Pike RK; Graham SJ; Ormsby ED; Bogard HA J Pharm Biomed Anal; 1996 May; 14(7):793-800. PubMed ID: 8809703 [TBL] [Abstract][Full Text] [Related]
5. The Montreal Protocol and metered dose inhalers. Navarro RP Med Interface; 1997 Apr; 10(4):135-6. PubMed ID: 10166800 [No Abstract] [Full Text] [Related]
6. Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part II: Archival calibration. Marple VA; Olson BA; Santhanakrishnan K; Mitchell JP; Murray SC; Hudson-Curtis BL J Aerosol Med; 2003; 16(3):301-24. PubMed ID: 14572327 [TBL] [Abstract][Full Text] [Related]
7. Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer. Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW Int J Pharm; 1999 Nov; 189(2):205-14. PubMed ID: 10536249 [TBL] [Abstract][Full Text] [Related]
8. [Adaptations of the European Respiratory Society guidelines by the Aerosol Therapy Group of the French Lung Society on the use of aerosol therapy through nebulization]. Becquemin MH; Chaumuzeau JP Rev Mal Respir; 2004 Nov; 21(5 Pt 1):889-90. PubMed ID: 15622332 [No Abstract] [Full Text] [Related]
9. Effect of inherent variability of inhalation products on impactor mass balance limits. Bagger-Jörgensen H; Sandell D; Lundbäck H; Sundahl M J Aerosol Med; 2005; 18(4):367-78. PubMed ID: 16379613 [TBL] [Abstract][Full Text] [Related]
10. [Adaptations of the European Respiratory Society guidelines by the Aerosol Therapy Group of the French Lung Society on the use of aerosol therapy through nebulization]. Boe J; Dennis JH; O'Driscoll BR; Bauer TT; Carone M; Dautzenberg B; Diot P; Heslop K; Lannefors L; Rev Mal Respir; 2004 Nov; 21(5 Pt 1):1033-8. PubMed ID: 15622355 [No Abstract] [Full Text] [Related]
11. [Practice guidelines of aerosol therapy through nebulization. Proposals from the National Assizes on Nebulization, Paris, April 4-5, 1997 (version from September 15 1997)]. Arch Pediatr; 1998 Feb; 5(2):175-80. PubMed ID: 10223140 [TBL] [Abstract][Full Text] [Related]
12. Challenges and scientific issues in the standardization of botanicals and their preparations. United States Pharmacopeia's dietary supplement verification program--a public health program. Srinivasan VS Life Sci; 2006 Mar; 78(18):2039-43. PubMed ID: 16516244 [TBL] [Abstract][Full Text] [Related]
13. Standards of aerosol therapy. Klein AV; Roufail P CMAJ; 1993 Nov; 149(9):1226. PubMed ID: 8221469 [No Abstract] [Full Text] [Related]
14. Discriminating Ability of Abbreviated Impactor Measurement Approach (AIM) to Detect Changes in Mass Median Aerodynamic Diameter (MMAD) of an Albuterol/Salbutamol pMDI Aerosol. David Christopher J; Patel RB; Mitchell JP; Tougas TP; Goodey AP; Quiroz J; Andersson PU; Lyapustina S AAPS PharmSciTech; 2017 Nov; 18(8):3296-3306. PubMed ID: 28589305 [TBL] [Abstract][Full Text] [Related]
15. Standardization procedure for determination of aerosol delivery of nebulizers by phenolsulfonphthalein aerosols; preliminary report. ABRAMSON HA; REITER C Ann Allergy; 1949; 7(3):390-2. PubMed ID: 18144690 [No Abstract] [Full Text] [Related]
16. Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols. Part 3. Final report on a statistical procedure for determining equivalence. Christopher D; Adams W; Amann A; Bertha C; Byron PR; Doub W; Dunbar C; Hauck W; Lyapustina S; Mitchell J; Morgan B; Nichols S; Pan Z; Singh GJ; Tougas T; Tsong Y; Wolff R; Wyka B AAPS PharmSciTech; 2007 Nov; 8(4):E90. PubMed ID: 18181550 [TBL] [Abstract][Full Text] [Related]
17. Pharmacopeial methodologies for determining aerodynamic mass distributions of ultra-high dose inhaler medicines. Wong W; Crapper J; Chan HK; Traini D; Young PM J Pharm Biomed Anal; 2010 Mar; 51(4):853-7. PubMed ID: 19932579 [TBL] [Abstract][Full Text] [Related]
18. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer. Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549 [TBL] [Abstract][Full Text] [Related]
19. [Functionality of inhalation aerosols is inadequate or lost at low temperature]. Lundgren HW; Holmér I; Lidén G Lakartidningen; 2001 Mar; 98(13):1508-11. PubMed ID: 11330145 [TBL] [Abstract][Full Text] [Related]
20. Parametric two-tier sequential quality assurance test of delivery dose uniformity of multiple-dose inhaler and dry powder inhaler drug products. Tsong Y; Shen M; Lostritto RT; Poochikian GK J Biopharm Stat; 2008; 18(5):976-84. PubMed ID: 18781529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]